These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10513736)

  • 1. Implication of fibrate therapy for homocysteine.
    Jonkers IJ; de Man FH; Onkenhout W; van der Laarse A; Smelt AH
    Lancet; 1999 Oct; 354(9185):1208. PubMed ID: 10513736
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum homocysteine increases after therapy with fenofibrate or bezafibrate.
    Dierkes J; Westphal S; Luley C
    Lancet; 1999 Jul; 354(9174):219-20. PubMed ID: 10421307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial.
    Jonkers IJ; Mohrschladt MF; Westendorp RG; van der Laarse A; Smelt AH
    Am J Med; 2002 Mar; 112(4):275-80. PubMed ID: 11893366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy.
    de Man FH; Nieuwland R; van der Laarse A; Romijn F; Smelt AH; Gevers Leuven JA; Sturk A
    Atherosclerosis; 2000 Oct; 152(2):407-14. PubMed ID: 10998469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia.
    Jonkers IJ; de Man FH; van der Laarse A; Frölich M; Gevers Leuven JA; Kamper AM; Blauw GJ; Smelt AH
    J Hypertens; 2001 Apr; 19(4):749-55. PubMed ID: 11330878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-suppressing effects of omega-3 fatty acids in bezafibrate-treated patients with isolated hypertriglyceridemia.
    Krysiak R; Gdula-Dymek A; Okopien B
    Eur J Intern Med; 2012 Sep; 23(6):e166-7. PubMed ID: 22863445
    [No Abstract]   [Full Text] [Related]  

  • 7. Omega-3 fatty acids enhance monocyte-suppressing effect of bezafibrate in patients with isolated hypertriglyceridemia.
    Krysiak R; Gdula-Dymek A; Okopien B
    Eur J Intern Med; 2012 Oct; 23(7):e171-2. PubMed ID: 22854277
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Westphal S; Dierkes J; Luley C
    Lancet; 2001 Jul; 358(9275):39-40. PubMed ID: 11454380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bezafibrate in an infant with congenital generalized lipodystrophy and severe hypertriglyceridemia].
    Araújo RS; Ramos Ade P; Borges Mde A
    Arq Bras Endocrinol Metabol; 2013 Nov; 57(8):653-8. PubMed ID: 24343636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine.
    Lever M; George PM; Slow S; Elmslie JL; Scott RS; Richards AM; Fink JN; Chambers ST
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):395-401. PubMed ID: 19653086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed bezafibrate-induced angio-oedema in a 68-year-old man.
    Frendo M; Theuma R; Fava S
    Br J Clin Pharmacol; 2007 Oct; 64(4):560-1. PubMed ID: 17610533
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal lipid profiles on fibrate derivatives.
    McLeod AJ; Warren RJ; Armitage M
    Lancet; 1996 Jan; 347(8996):261. PubMed ID: 8551900
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemostatic effects of omega-3 fatty acids in isolated hypertriglyceridemic patients treated with bezafibrate.
    Krysiak R; Okopien B
    Eur J Intern Med; 2012 Sep; 23(6):e168-9. PubMed ID: 22863446
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients.
    Fukushima M; Taniguchi A; Sakai M; Doi K; Nagata I; Nagasaka S; Tokuyama K; Nakai Y
    Diabetes Care; 2000 Feb; 23(2):259. PubMed ID: 10868845
    [No Abstract]   [Full Text] [Related]  

  • 15. Coagulofibrinolytic assessment of effects of bezafibrate on hypertriglyceridemia in postmenopausal women.
    Ushiroyama T; Ikeda A; Higashio S; Ueki M
    Blood Coagul Fibrinolysis; 2000 Dec; 11(8):709-14. PubMed ID: 11132648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy.
    Geraix J; de Souza ME; Delatim FC; Pereira PC
    Braz J Infect Dis; 2006 Jun; 10(3):159-64. PubMed ID: 17568845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fenofibrate and gemfibrozil on plasma homocysteine.
    Chan NN; Chow FC
    Lancet; 2001 Nov; 358(9295):1811; author reply 1811-2. PubMed ID: 11734263
    [No Abstract]   [Full Text] [Related]  

  • 18. Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
    Arbel Y; Klempfner R; Erez A; Goldenberg I; Benzekry S; Shlomo N; Fisman EZ; Tenenbaum A;
    Cardiovasc Diabetol; 2016 Jan; 15():11. PubMed ID: 26794137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of fibrate therapy for homocysteine.
    Chan N; Chan JC
    Lancet; 1999 Oct; 354(9185):1208-9. PubMed ID: 10513737
    [No Abstract]   [Full Text] [Related]  

  • 20. Bezafibrate to prevent relapsing pancreatitis in WAGR syndrome.
    Diacono D; Fagbemi A; Puleston J; Banerjee I
    BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23152176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.